- AbbVie’s hepatitis C drug Viekirax gets European approval
READ NEWS - AbbVie rival Gilead makes exclusive deal with CVS for hep C drugs
READ NEWS - Express Scripts Taking Harvoni off Formulary
READ NEWS - Abbvie Drugs Approved by FDA
READ NEWS - Ledipasvir Sofosbuvir Combination Cuts Cirrhotic Hepatitis C
READ NEWS - Good Old Aspirin Might Protect Against Liver Fibrosis
READ NEWS - An interferon-free antiviral regimen for HCV after liver transplantation
READ NEWS - ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients
READ NEWS - Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis
READ NEWS - Hepatitis C in Children: Comorbidities and Quality of Life
READ NEWS - Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)
READ NEWS - Hepatitis C vaccine shows promise in early clinical trial
READ NEWS - Popular HCV Drug Combo Wins FDA Backing
READ NEWS - United Health Care - F3/F4 - AASLD/IDSA Guidance
READ NEWS - (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C is FDA Approved
READ NEWS - Bristol-Myers pulls U.S. marketing application for hepatitis C treatment
READ NEWS
Looking for volunteers to participate in a study about Mishel’s Theory of Uncertainty in Illness Among Baby Boomers with Hepatitis C. Participation is completely anonymous and participants may withdraw at any time. Thank you for your participation.
To view the survey, please click on this link:
www.SurveyMonkey.com/S/UncertaintyHepC
- During 2014, Hepatitis C Association will continue to provide patients in substance abuse treatment centers with instructor led presentations about hepatitis C throughout the United States. For information, please call 908.769.8479. With specific sponsorship from Boehringer Ingelheim Pharmaceuticals, ten presentations are already scheduled in the State of Maryland.
- The International Liver Conference (EASL)
London, United Kingdom
April 9 – 13 - Digestive Diseases Week (DDW)
Chicago, IL
May 4 – 6 - The Liver Meeting (AASLD)
Boston, MA
November 7 – 11 - American Public Health Association Meeting & Exposition (APHA)
New Orleans, LA
November 15 – 19
This site complies with the HONcode standard for trustworthy health information:
verify here.
The information provided on this site is intended to support, not replace, the relationship that exists between a patient and his/her physician. Hepatitis C Association does not display commercial content or receive funding from advertising products or services.
Support line: 877-HELP-4-HEP (877-435-7443)
In My Own Words... Essay Contest!
The ATTC Network Coordinating Office, in partnership with Faces & Voices of Recovery Harm Reduction Coalition, Hepatitis C Association and Help4Hep invite you to share YOUR STORY OF RECOVERY from a substance use and/or mental health disorder while coping with Hepatitis C.
> Learn More
Vertex Patient Assistance for Incivek
855-837-8394 | www.incivek.com
Genentech Patient Assistance for
Pegasys & Copegus | 888-941-3331
Merck Patient Assistance for Victrelis
Peglntron & Rebetol
866-939-4372
Johnson & Johnson Patient
Assistance Foundation
800-652-6227 | www.jjpaf.org
Olysio Support (Medicare Excluded)
855-5-OLYSIO | www.olysio.com
Patient Access Network (PAN) Foundation for underinsured patients 866-316-PANF | www.panfoundation.org
Gilead Patient Assistance for Sovaldi
855-769-7284 | www.mysupportpath.com
